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Background
Economic value is an important component of healthcare
policy decision making. The primary currency for com-
paring the value of competing healthcare interventions is
the Cost per Quality Adjusted Life Year (QALY) gained.
Aim





Patients who had an LESI between June 2012 and July
2013 and had EQ-5D scores available before and after
LESIs were identified. Costs were calculated based on
the Medicare Fee Schedule multiplied by the number of
LESIs done between the two clinic visits. QALYs were
calculated using the EQ-5D.
Results
There were 257 patients (157 females, 100 males), mean
age 60.0 years (21 to 88) years. Cost per LESI was $608,
with most patients receiving 3 LESIs over one year (range
1 to 6). The mean QALY gained was -0.006. One hundred
twenty-two patients (47%) had a gain in QALY (mean=
0.083) at a cost of $16,503 per QALY gained, 103 had a
loss in QALY (mean = -0.112) and 32 had no gain in
QALY. Ten of the 122 patients who improved, and 19 of
the 135 patients that did not improve had medical comor-
bidities that precluded surgery. Of the 112 patients who
improved without medical comorbidities, 31 (28%) subse-
quently had surgery. Of the 116 patients who did not
improve and had no medical comorbidities, 45 (39%) sub-
sequently had surgery. This proportion is statistically sig-
nificantly different at p=0.05. Although the patients who
had surgery even after improvement with LESI had a
lower mean QALY gain (0.067) compared to those that
did not have surgery (0.089), this was not statistically sig-
nificant (p=0.260).
Conclusions
This study indicates that at LESI may not be a cost-effec-
tive intervention in patients with low back pain. For the
122 patients who improved, cost per QALY gained was
acceptable at $16,503. However for the 135 patients with
no gain or a loss in QALY, the economics are unreporta-
ble with a cost per QALY gained being theoretically infi-
nite. Further studies are needed in order to identify
specific patient populations that will benefit from LESI, as
the economic viability of LESI requires improved patient
selection.
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